Search
for

    Sort by

    Research 721–750 of 1000+

    1. Medikamentöse Therapie der BPH Ist eine Kombinationstherapie mit 5α-Reduktasehemmern und α-Rezeptorenblockern sinnvoll? Der Urologe · 2002 · 4 citations
    2. The post-finasteride syndrome: possible etiological mechanisms and symptoms International journal of impotence research · 2023 · 3 citations
    3. Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules BMC chemistry · 2022 · 3 citations
    4. Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial The Journal of Urology · 2021 · 3 citations
    5. Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial Molecular genetics and metabolism · 2019 · 3 citations
    6. WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH Therapeutic advances in urology · 2019 · 3 citations
    7. Why Odds Ratios Can Be Tricky Statistics The Journal of Clinical Psychiatry · 2018 · 3 citations
    8. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system Research and reports in urology · 2016 · 3 citations
    9. 5ARIs and PSA: Evidences Urologia Journal · 2014 · 3 citations
    10. Homologous recombination induced by doxazosin mesylate and saw palmetto in the <i>Drosophila</i> wing‐spot test 2011 · 3 citations
    11. Doxazosin and finasteride alone or in combination: the PREDICT study BJUI · 2003 · 3 citations
    12. Clinical use of 5α-reductase inhibitors Cambridge University Press eBooks · 2001 · 3 citations
    13. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 3 citations
    14. GYNECOMASTIA AFTER FINASTERIDE THERAPY Southern Medical Journal · 1995 · 3 citations
    15. Role of 5α-reductase inhibitors in androgen-stimulated skin disorders. PubMed · 2013 · 3 citations
    16. HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors Discover Chemistry. · 2025 · 2 citations
    17. Scientific Evaluation of A Unani Pharmacopoeia-Based Formulation on BPH in Animal Model International Journal of Preventive Medicine and Health (IJPMH) · 2023 · 2 citations
    18. Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia BJUI · 2023 · 2 citations
    19. 5‐Alpha reductase inhibitor related litigation: A legal database review International Journal of Andrology · 2021 · 2 citations
    20. Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis Asian Journal of Andrology · 2021 · 2 citations
    21. Medical Therapies for Treatment of BPH: Special Considerations in Elderly Men Current Geriatrics Reports · 2019 · 2 citations
    22. Acute gross hematuria: etiology and management CRC Press eBooks · 2019 · 2 citations
    23. Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS 2019 · 2 citations
    24. Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors Indian Journal of Pharmaceutical Education · 2018 · 2 citations
    25. Prescribing to save patients money: Ethical considerations Journal of The American Academy of Dermatology · 2018 · 2 citations
    26. Discriminating in favour of or against men with increased risk of finasteride-related side effects? Experimental Dermatology · 2016 · 2 citations
    27. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system DOAJ (DOAJ: Directory of Open Access Journals) · 2016 · 2 citations
    28. Reversible visual loss caused by combination therapy of alfuzosin and finasteride in a patient with uveitic glaucoma Cutaneous and Ocular Toxicology · 2012 · 2 citations
    29. Testosterone metabolite nonessential for androgen effects Nature Reviews Endocrinology · 2012 · 2 citations
    30. 황금(黃芩)이 전립선비대증(前立腺肥大症) Rat에 미치는 영향 The Journal of Internal Korean Medicine · 2009 · 2 citations